WHO AFRO TDR Impact Grants 2026 Open for African Researchers

Establishing an independent research track record is a critical milestone for early-career health scholars across Africa. The WHO AFRO Impact Grants 2026 program—a joint initiative between the World Health Organization Regional Office for Africa and TDR (the Special Programme for Research and Training in Tropical Diseases)—offers accessible seed funding aimed exclusively at African-led teams. Designed to bridge the gap between proven health interventions and real-world delivery, this small-grant mechanism provides a direct pathway to secure WHO-branded principal investigator experience without competing against European or North American consortia.

Call for Applications Overview

Joint WHO AFRO Impact Grants for Implementation Research for Regional Priorities 2026–2027

• Funding Bodies: World Health Organization Regional Office for Africa (WHO AFRO) and the UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR).

• Target Candidates: Early-career researchers, female scientists, and research teams based in African institutions (including ministries of health, national disease control programs, universities, research institutes, and NGOs).

• Eligible Research Priorities:

  1. Person-Centred Service Delivery: Integration of communicable disease care (TB, malaria, neglected tropical diseases), primary health care models, referral mechanisms, and continuity of care.

  2. Health Systems Strengthening & Digital Health: Addressing bottlenecks in essential medicines access, diagnostics, laboratory supply chains, digital health tools, AI applications, and emergency preparedness.

  3. Environmental Health & Climate Resilience: Climate-sensitive disease surveillance, WASH integration into primary care, One Health approaches, and antimicrobial resistance (AMR) containment.

• Eligibility & Hard Requirements:

  • Institutional Base: The Principal Investigator (PI) and the majority of the team must be affiliated with an eligible institution located in the WHO African Region.

  • Geographic Scope: Must be conducted within the WHO African Region. (Note: Egypt, Libya, Tunisia, Morocco, and Sudan belong to the WHO Eastern Mediterranean Region and are not eligible).

  • Mandatory Documents: A single combined PDF submission containing a completed signed WHO application form, a 1-page PI CV (with contact details, WhatsApp number, and family name underlined), a project budget, an authorization letter (if working within health facilities), and an official acknowledgment letter signed by a public health/service manager.

• Grant Value & Duration:

  • Up to $15,000 USD per grant (allocated for project implementation costs, not salary stipends).

  • Maximum duration of 12 months, with all activities required to wrap up by December 31, 2027 (no-cost extensions are strictly prohibited).

• Deadlines & Submission Format:

  • Portal Closing Cutoff: Tuesday, 15 September 2026 at 17:00 CEST .

  • Submission Platform: Applications must be submitted via the online eTDR Community Site in English, French, or Portuguese. Consult this guide for more information on how to submit an application in eTDR.

• Hint:

  • Focus strictly on implementation science (how to scale or deliver known, effective health interventions) rather than clinical efficacy trials, basic laboratory science, or descriptive prevalence surveys.

  • Co-design your research proposal alongside local or national public health program officers to ensure findings directly address operational health bottlenecks.

Strategic Implementation Insights

The selection panel for the WHO AFRO Impact Grants priorities actionable research that improves health system operations. Proposals that attempt to test new clinical interventions or conduct broad baseline surveys without an implementation focus are routinely rejected. Successful applicants clearly articulate how their findings will immediately inform local health policy, improve supply chain delivery, or optimize community-level service distribution. Securing the manager’s acknowledgment letter early is vital, as it serves as primary proof that your research responds directly to institutional needs.

Frequently Asked Questions

Is this grant intended to fund basic clinical research or drug trials?

No. The WHO AFRO Impact Grants program strictly supports implementation and operational research. Projects evaluating the efficacy of unproven drugs, conducting animal studies, or carrying out pure prevalence surveys fall outside the scope of this call.

Can researchers from North African countries apply?

Only researchers based in member states belonging to the WHO African Region (AFRO) are eligible. North African nations such as Egypt, Morocco, Tunisia, and Libya are governed under the WHO Eastern Mediterranean Region (EMRO) and cannot apply under this call.